Hi, request for special situation CVR from Bristol Myers Squibb trading on New York stock exchange to be added in next few weeks. Ticker (BMY RT:NYQ). Currently trading at $2 dollar and will jump to $9 if drug approvals are met in next few months. Obviously will drop to zero if no approval but I would say there is a very high probability of approval.